IL1B and type 1 diabetes mellitus: These signs of activation of the innate immune system are partly consistent with reports of IFN-α/γ and IL-1β pathway activation associated with altered Toll-like receptor responsiveness and enhanced nuclear factor (NF)-κB signaling in the dendritic cells (DCs) and monocytes of newly diagnosed T1D patients [9,26].